EN PL
SHORT COMMUNICATION
Primary and secondary osteoporosis. Guidelines for rheumatologists
 
More details
Hide details
 
Online publication date: 2012-11-06
 
 
Reumatologia 2012;50(5):370-377
 
KEYWORDS
ABSTRACT
Osteoporosis is defined as a systemic skeletal disease and the clinical significance of osteoporosis lies in the fractures that arise. General guidance is provided and the following areas are reviewed: assessment of fracture risk, bone mineral density measurement for the diagnosis of osteoporosis, investigation of patients, general and pharmacological management of osteoporosis, monitoring of treatment.
REFERENCES (7)
1.
Lorenc R, Głuszko P, Karczmarewicz E i wsp. Zalecenia postępowania diagnostycznego i leczniczego w osteoporozie. Aktualizacja 2011. Medycyna Praktyczna, wyd. spec. 1/2011.
 
2.
Kanis JA, Burlet N, Cooper C, et al., on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) European guidance for diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis Int 2008; 19: 399-428.
 
3.
Burger H, de Laet CE, van Daele PL, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol 1998; 147: 871-879.
 
4.
Alendronate, etidronate, risedronate, raloksifene, and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. NICE technology appraisal guidance 180 (amended), July 2010.
 
5.
Alendronate, etidronate, risedronate, raloksifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. NICE technology appraisal guidance 161 (amended), July 2010.
 
6.
Denosumab for the prevention of osteoporotic fractures in postmenausal women. NICE technology appraisal guidance 204, October 2010.
 
7.
Lekamwasam S, Adachi JD, Agnusdei D, et al. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 2012; 23: 2257-2276.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top